$SN

Blowout Guidance Sends SharkNinja Shares Higher

SharkNinja (SN) reported Q2 2026 net sales of $1.77B (up 22.2% YoY) and adjusted net income of $178M (up 29%). The company raised full-year 2026 guidance, targeting up to 17% sales growth and $6.55 adjusted EPS. SN shares have risen 56% YTD, supported by institutional demand and strong fundamentals, including 3-year sales growth of 20% and EPS growth of 63.8%.

Original reporting
Published Sep 3, 2026, 7:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 3, 2026, 8:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Blowout Guidance Sends SharkNinja Shares Higher — source image
Decision brief

The 30-second read

$SNBullishHigh
01

Why it matters

The earnings beat and guidance lift may attract additional institutional buying.

02

Market read

Earnings surprise and guidance raise provide a clear trading catalyst for SN.

03

What to watch

Potential supply‑chain constraints or competition could temper growth.

Relevance 8/10Novelty 8/10Timing: post‑earnings release

Background

SharkNinja (SN) reported Q2 FY2026 results with strong sales growth and raised FY guidance.

Company-level read

Ticker impact

$SNBullishHigh confidence
Context

Q2 FY2026 earnings posted $1.77B sales and EPS $1.26, guidance raised to up to $6.55 EPS.

Expected impact

stock may rally on the news, especially in after‑hours trading.

Evidence & confidence

Earnings beat and higher guidance are fresh primary disclosures for a mid‑cap consumer‑goods company.

Market effects

Positive signal for consumer‑durables sector, may lift peers.

U.S. consumer discretionary outlook improves.

Limited to U.S. markets; modest global ripple.

Counterpoint

If guidance already priced in, the rally could be short‑lived.

Key entities

  • SharkNinja

    Consumer products maker listed on NYSE under ticker SN.

Related articles

$SNHighAI 8/10

Smith & Nephew merger talks with J&J orthopaedics unit collapse over CEO role, FT reports

Smith & Nephew's merger talks with Johnson & Johnson's orthopaedics unit collapsed over disagreement on the CEO role, according to the Financial Times. The deal would have valued the unit at up to $22 billion, nearly double Smith & Nephew's market cap. Both companies were aligned on financial terms but disagreed on leadership. Smith & Nephew's former CEO left in 2019 over pay demands.

$SNMed

UBS sees attractive risk/reward in three European medtech into Q3 results

UBS identifies Convatec, Smith & Nephew, and Sonova as attractive European medtech stocks ahead of Q3 results, citing revenue and earnings growth expectations. Convatec is expected to report 6% organic growth, Smith & Nephew may undergo a strategic review, and Sonova could raise guidance due to market growth and currency tailwinds. UBS provides price targets for each company.

$SNMed

UBS raises SharkNinja stock price target to $219 on product expansion

UBS raised its price target for SharkNinja (NYSE:SN) to $219.10 from $147 and kept a Buy rating, citing Q2 results and faster product launches. The firm pointed to 13 new products year to date versus nine in the first eight months of 2025, plus plans for up to three new subcategories in 2026. SN trades at $187.68 and reported revenue of $1.77B (+22.2%) with adjusted EPS of $0.92.

$SNHighAI 9/10

SharkNinja Q2 Earnings Call Highlights

SharkNinja (NYSE:SN) reported Q2 call updates on product launches, including the Ninja Crispi Microwave and plans to reach a 41st subcategory by end of Q3. International revenue rose, with U.K. up 18.7% to $255M. Adjusted gross margin fell to 48.7% on tariffs. Adjusted EPS guidance raised to $6.45-$6.55 and net sales to +16%-17%, aided by a $247.1M tariff refund accepted by U.S. Customs.